PD-L1 抗体
Our Local Distributor
北京 101111
Quick Overview for PD-L1 抗体 (ABIN7266180)
抗原
See all PD-L1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
原理
- PD-L1/CD274 Rabbit mAb
-
交叉反应
- 人
-
产品特性
- Monoclonal Antibodies
-
纯化方法
- Affinity purification
-
纯度
- ≥95 % purity by SDS-PAGE
-
免疫原
- Recombinant protein of human PD-L1/CD274.
-
亚型
- IgG
-
-
-
-
应用备注
- Elisa,1:500 - 1:2000,WB,1:500 - 1:2000,FC,1:50 - 1:200,Inhibition,1 μg/ul
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.09 % sodium azide, 50 % glycerol, pH 7.4.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- PD-L1 (CD274 (PD-L1))
-
别名
- PD-L1
-
背景
- Programmed death-ligand 1 (PD-L1) is a 40 kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and non-hematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1-PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PD-L1 has become an important biomarker and immunotherapy target for many types of malignancies.,B7-H,B7H1,PDL1,PD-L1,PDCD1L1,PDCD1LG1,CD274,Immunology & Inflammation,CD markers,PD-L1
-
分子量
- 20kDa/33kDa
-
基因ID
- 29126
-
UniProt
- Q9NZQ7
-
途径
- Cancer Immune Checkpoints
抗原
-